Deliver to United Kingdom
0

HPLC column NUCLEODUR ® Sphinx RP, 3 µm, 150 mm, 2 mm

£ 778.86*

*Prices plus VAT plus shipping costs

£ 934.63*

*incl. VAT, plus shipping costs

HPLC column NUCLEODUR ® Sphinx RP, 3 µm, 150 mm, 2 mm

Order number: 355H.1

Part number: AC100007482

In Stock

Price Breakdown

1

6

24

Structured to assist in consistent experimental procedures, the Hplc Column Nucleodur ® Sphinx Rp, 3 μm, 150 Mm, 2 Mm offers a unique selectivity due to its bifunctional RP phase composed of a balanced ratio of propylphenyl and C 18 ligands. This column is designed for reversed phase (RP) separations and is suitable for quinolone antibiotics, substituted aromatics, sulfonamides, xanthines, and applications involving additional π-π interactions. With a pore size of 110 Å, particle size of 3 μm, and pressure stability up to 600 bar, this column ensures reliable performance under various conditions. Its specific surface area of 340 m²/g provides ample interaction sites for efficient separations. The column's temperature stability

  • Category: Separation columns for HPLC
  • Separation principle: Reversed phase (RP)
  • Phase: Sphinx RP
  • Column shape: Analytical separation column
  • Temperature stability: 60 ° C
  • Particle size: 3 µm
  • Pressure stability: 600 bar
  • Column type: HPLC column
  • pH stability: 1,0-10,0
  • Specific surface according to BET: 340 m²/g
  • Surface chemistry: Bifunctional RP phase, balanced ratio of propylphenyl and C 18 ligands
  • Endcapped: yes
  • Column volume: 0.45 ml
  • Particle type: Fully porous particles (FPP)
  • Recommended application(s): Quinolone antibiotics Suitable for LC-MS Substituted aromatics Sulfonamides Xanthines Additional π-π interactions
  • USP listing: L1 L11
  • Pore volume: 0.9 ml/g
  • Interactions / retention mechanism: π-π and hydrophobic
  • L x Ø internal (column): 150 x 2 mm
  • Eluent in column: Acetonitrile - Water
  • Pore size: 110 Å
allied chemi
  • secure-payment
  • visa
  • american-express
  • master-card

© 2026 Copyright. All Rights Reserved.